EUVIMEDEUVIMED entdecken
Crossref

Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway

Dan Pan, Jikai Xia, Yilun Qu, Chunru Shi, Hongjian Du, Jie Zhang, Fei Peng, Xu Wang, Ran Liu, Lingling Wu, Quan Hong, Xiangmei Chen

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Dan Pan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State K…. Hauptthemen laut MEDLINE: Oleanolic Acid, Mesangial Cells, Glomerulonephritis, Membranoproliferative, Anti-Inflammatory Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanxi Provincial Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mesangial proliferative glomerulonephritis (MsPGN) is a common form of glomerulonephritis characterized by mesangial cell proliferation and inflammatory responses. However, current clinical treatment options for MsPGN are rather limited. Oleanolic acid (OA), a natural pentacyclic triterpenoid compound, exhibits anti-tumor and anti-inflammatory properties and has been proven to have renal protective effects. We speculate that OA could potentially serve as an alternative therapy for MsPGN. OBJECTIVE: This study aimed to investigate the therapeutic efficacy and mechanism of OA against MsPGN. METHODS: Tail vein injection of anti-Thy1 antibody was used to establish the MsPGN model, followed by a comprehensive assessment of the effects of OA on renal function, histopathological changes, and inflammatory responses in anti-Thy1 nephritis rats. Subsequently, network pharmacology was employed to predict the key targets and pathways of OA in treating MsPGN. Finally, in vivo and in vitro experiments were conducted to validate the results of network pharmacology. RESULTS: OA significantly improved renal function, and attenuated mesangial cell proliferation and inflammatory reactions in anti-Thy1 nephritis rats. Network pharmacology analysis identified TNF-α, IL-6, IL-1β, MAPK3, and AKT1 as key targets of OA in the treatment of MsPGN, and involved the IL-17 signaling pathway. Additionally, we observed increased phosphorylation levels of ERK and AKT, as well as activation of downstream inflammatory responses, in both anti-Thy1 nephritis rats and mesangial cells stimulated with IL-17. In contrast, treatment with OA and the ERK inhibitor PD98059 reversed these effects. Furthermore, we identified IL17RA within this pathway as a potential target of OA. CONCLUSIONS: Our study demonstrates that OA can modulate the IL-17/ERK/AKT signaling pathway, thereby improving anti-Thy1 antibody-induced MsPGN. This establishes a theoretical basis for OA to potentially serve as a therapeutic agent for treating MsPGN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oleanolic AcidMesangial CellsGlomerulonephritis, MembranoproliferativeAnti-Inflammatory AgentsAnimalsProto-Oncogene Proteins c-aktCell ProliferationInterleukin-17RatsRats, Sprague-DawleyMaleSignal TransductionDisease Models, AnimalHumansExtracellular Signal-Regulated MAP KinasesMAP Kinase Signaling SystemCells, CulturedThy-1 AntigensIsoantibodies

Stichwörter der Autor:innen

IL-17/ERK/AKT pathwayInflammatory responseMesangial cells proliferationMesangial proliferative glomerulonephritisNetwork pharmacologyOleanolic acid

Substanzen

Oleanolic AcidProto-Oncogene Proteins c-aktInterleukin-17Anti-Inflammatory Agentsanti-Thy antibodyExtracellular Signal-Regulated MAP KinasesThy-1 AntigensIsoantibodies

Autor:innen und Institutionen

  • Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center fo…

Förderung

  • National Natural Science Foundation of China
  • Shanxi Provincial Key Research and Development Project

Zitieren

APA

Pan, D., Xia, J., Qu, Y., Shi, C., Du, H., Zhang, J., Peng, F., Wang, X., Liu, R., Wu, L., Hong, Q., & Chen, X. (2025). Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114459

Vancouver

Pan D, Xia J, Qu Y, Shi C, Du H, Zhang J, et al. Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114459

BibTeX
@article{Pan2025,
  author = {Pan, Dan and Xia, Jikai and Qu, Yilun and Shi, Chunru and Du, Hongjian and Zhang, Jie and Peng, Fei and Wang, Xu and Liu, Ran and Wu, Lingling and Hong, Quan and Chen, Xiangmei},
  title = {Oleanolic acid inhibits mesangial cell proliferation and inflammatory response in mesangial proliferative glomerulonephritis through IL-17/ERK/AKT pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114459}
}
Kostenlos starten →